Richard L. Gallo
Division of Dermatology, University of California, San Diego
Affiliated withUniversity of California, San Diego VA San Diego Healthcare Center
Research Area
Biography
Richard L. Gallo has not added Biography.
If you are Richard L. Gallo and would like to personalize this page please email our Author Liaison for assistance.
JoVE Journal Publications
Article Total : 1 | Year |
|---|---|
 Publication title Cited by 1 | 2012 |
Other Publications
Article | Year |
|---|---|
| 2002 | |
| 2002 | |
| 2002 | |
| 2002 | |
| 2002 | |
| 2002 | |
| 2002 | |
| 2002 | |
| 2002 | |
| 2003 | |
| 2003 | |
| 2003 | |
| 2003 | |
| 2003 | |
| 2003 | |
Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology| PubMed ID: 14724813 | 2003 |
| 2004 | |
| 2004 | |
| 2004 | |
| 2004 | |
| 2004 | |
| 2004 | |
| 2004 | |
| 2004 | |
| 2004 | |
| 2005 | |
| 2005 | |
| 2005 | |
| 2005 | |
| 2005 | |
| 2005 | |
Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 15814717 | 2005 |
| 2005 | |
| 2005 | |
| 2005 | |
| 2005 | |
Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. The Journal of investigative dermatology| PubMed ID: 16098035 | 2005 |
| 2005 | |
| 2005 | |
| 2005 | |
| 2006 | |
The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 16394265 | 2006 |
| 2006 | |
| 2006 | |
| 2006 | |
| 2006 | |
| 2006 | |
| 2006 | |
| 2006 | |
| 2006 | |
| 2006 | |
Impairment of innate immune killing mechanisms by bacteriostatic antibiotics. FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 17215486 | 2007 |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2008 | |
| 2008 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2007 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 18198218 | 2008 |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2008 | |
| 2009 | |
| 2008 | |
| 2008 | |
| 2009 | |
| 2009 | |
| 2009 | |
| 2009 | |
| 2009 | |
| 2009 | |
| 2009 | |
| 2009 | |
| 2008 | |
| 2009 | |
| 2009 | |
Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin. Journal of leukocyte biology| PubMed ID: 19638500 | 2009 |
Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. The Journal of investigative dermatology| PubMed ID: 19710683 | 2010 |
| 2009 | |
| 2009 | |
| 2009 | |
Fluorescence and UV resonance Raman study of peptide-vesicle interactions of human cathelicidin LL-37 and its F6W and F17W mutants. Biochemistry| PubMed ID: 19894716 | 2009 |
| 2010 | |
M1T1 group A streptococcal pili promote epithelial colonization but diminish systemic virulence through neutrophil extracellular entrapment. Journal of molecular medicine (Berlin, Germany)| PubMed ID: 19960175 | 2010 |
| 2009 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. Journal of innate immunity| PubMed ID: 20375578 | 2009 |
| 2009 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
| 2010 | |
Statins enhance formation of phagocyte extracellular traps. Cell host & microbe| PubMed ID: 21075355 | 2010 |
| 2011 | |
| 2011 | |
| 2010 | |
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. The Journal of clinical endocrinology and metabolism| PubMed ID: 21118827 | 2011 |
| 2010 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2011 | |
| 2012 | |
| 2011 | |
Clarification of DRIs for calcium and vitamin D across age groups. Journal of the American Dietetic Association| PubMed ID: 21963009 | 2011 |
Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Science translational medicine| PubMed ID: 21974936 | 2011 |
| 2011 | |
| 2011 | |
| 2011 | |
| 2012 | |
| 2012 | |
| 2012 | |
| 2012 | |
| 2012 | |
| 2012 | |
IOM committee members respond to Endocrine Society vitamin D guideline. The Journal of clinical endocrinology and metabolism| PubMed ID: 22442278 | 2012 |
| 2012 | |
PTH/PTHrP and vitamin D control antimicrobial peptide expression and susceptibility to bacterial skin infection. Science translational medicine| PubMed ID: 22623742 | 2012 |
| 2012 | |
| 2012 | |
| 2012 | |
| 2012 | |
| 2012 | |
| 2012 | |
| 2012 |